Please login to the form below

Not currently logged in
Email:
Password:

meningitis

This page shows the latest meningitis news and features for those working in and with pharma, biotech and healthcare.

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Those sales were up by 20.1%, reflecting the recovery and growth of its Pentaxim vaccine in China, along with meningitis vaccine Menactra’s growth in emerging markets.

Latest news

More from news
Approximately 14 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    The work was centred around an awareness campaign on meningococcal meningitis, and the need for vaccination, targeting 15-24-year olds – the second highest at-risk group in the UK. ... In a campaign first, Pfizer granted full creative licence to ten

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    One example is the Teddy Bears’ Picnic on the banks of the river Thames near Tower Bridge, which aimed to raise awareness of bacterial meningitis.

  • Pharma deals in June 2015 Pharma deals in June 2015

    When GSK acquired two additional rival meningitis vaccines from Novartis, namely Menveo and Bexsero, the European Commission and other antitrust regulators were concerned that this gave GSK too much power in ... As a result GSK has sold two of its own

  • Pharma deals during July 2014 Pharma deals during July 2014

    The transaction includes two vaccines currently marketed outside the US and primarily in Europe: NeisVac-C, a vaccine against group C meningococcal meningitis (MenC), and FSME-IMMUN against tick-borne encephalitis

  • Pharma deals during April 2014 Pharma deals during April 2014

    franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US. Also included in the meningitis “goodie

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Power to the People: Why consultation is key for improved patient outcomes

    Our roadmap. When it comes to developing a Roadmap to Defeat Meningitis, Meningitis Research Foundation is using the public consultation to gather vital views and generate new advocates that will help ... To learn more about Meningitis Research

  • Why pharma content marketing campaigns should be agile

    Content. Be it a 44-page white paper on the symptoms of Meningitis or a two-minute YouTube video which demonstrates how to apply skin rash lotion, companies are discovering how

  • HAVAS Just::

    Abbvie. AstraZeneca. Caris Life Sciences. Lilly. Meningitis Trust. Mundipharma. Napp Pharmaceuticals.

  • Say Communications

    Leadiant Biosciences. MDNA Life Sciences. Meningitis Research Foundation. MZP Tech. Natia Care. ... Stefi Rucci. Managing Director. View LinkedIn profile.  . Meningitis Research Foundation has been working with Say Communications to help boost our

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics